Plasmacytoid DCs (pDCs) comprise one of two major subsets of human DCs. The myeloid subset is characterized by the presence of CD11c, whereas pDCs correspond to a small subset of CD11c-negative circulating blood DCs (1) . Human pDCs are CD4 + CD45RA + IL-3Rα + (CD123) ILT3 + ILT1 − CD11c − lineage − cells (2) . Two additional markers, BDCA-2 and BDCA-4 are expressed on human pDCs in peripheral blood and bone marrow (3) .
In response to viral and bacterial stimuli, pDCs can mature and produce large amounts of type I IFNs (IFN-α/β) (4) . Type I interferons activate NK cell cytolytic activity, but protect uninfected cells from NK cell-mediated lysis and aff ect T cell function by inducing Th1 diff erentiation (5) . Moreover, type I interferons promote diff erentiation, maturation, and immunostimulatory functions of DCs.
Recent fi ndings suggest that pDCs play an important role in the balance of immune responses.
Although resting pDCs may induce regulatory responses, their activated counterparts have a stimulatory capacity (6) . In patients with ovarian carcinoma, resting pDCs present at the tumor site may help to maintain an immuno suppressive environment (7) . Alternately, activated pDCs induce expansion of antigen-specifi c memory CD8 + T cells and Th1 CD4 + T cell populations specifi c for endogenous antigens (8) , infl uenza virus (9, 10) , and the MART-1/ melan A [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] epitope (11) . pDCs participate in innate immune responses against diff erent types of viruses, eliciting a potent Th1 polarization. During infl uenza viral infection, pDCs are able to prime virus-specifi c primary and secondary CD4 and CD8 T cell immune responses in vitro and in vivo (12) , but only when the pDCs are exposed to the replicative virus and not with nonreplicating, boiled, or ultraviolet-irradiated virus (9) . This important observation suggests that intracellular virus protein expression is essential for pDCs to present antigens in MHC class II. The poor capacity of freshly isolated Plasmacytoid dendritic cells (pDCs) contribute to innate antiviral immune responses by producing type I interferons. Although human pDCs can induce T cell responses upon viral infection, it remains unclear if pDCs can present exogenous antigens. Here, we show that human pDCs exploit Fc RII (CD32) to internalize antigen-antibody complexes, resulting in the presentation of exogenous antigen to T cells. pDCs isolated from melanoma patients vaccinated with autologous monocyte-derived peptide-and keyhold limpet hemocyanin (KLH)-loaded dendritic cells, but not from nonvaccinated patients or patients that lack a humoral response against KLH, were able to stimulate KLH-specifi c T cell proliferation. Interestingly, we observed that internalization of KLH by pDCs depended on the presence of serum from vaccinated patients that developed an anti-KLH antibody response. Anti-CD32 antibodies inhibited antigen uptake and presentation, demonstrating that circulating anti-KLH antibodies binding to CD32 mediate KLH internalization. We conclude that CD32 is an antigen uptake receptor on pDCs and that antigen presentation by pDCs is of particular relevance when circulating antibodies are present. Antigen presentation by pDCs may thus modulate the strength and quality of the secondary phase of an immune response.
human and mouse pDCs to induce T cell pro liferation is likely the result of their ineffi cient capturing of antigens, in contrast with classical DCs (1).
In vivo, pDCs accumulate at sites of infl ammation, suggesting that pDCs contribute to the ongoing infl ammatory response through the release of cytokines and chemokines and the activation of lymphocytes. Because of their capacity to secrete large amounts of type I interferons, it has been suggested that pDCs induce maturation of local myeloid DCs, facilitating cross-priming of endocytosed targets (13) . The ques tion whether pDCs themselves can exploit antigen uptake receptors and present exogenous antigens has spurred the current study.
How pDCs might endocytose exogenous antigens is virtually unknown. Uptake might occur via BDCA-2, a C-type lectin transmembrane glycoprotein (14) or via Fcγ receptors. pDCs express the low-affi nity Fcγ receptor (CD32). More specifi cally, pDCs express FcγRIIa (CD32a), but they lack FcγRIIb (CD32b) (15, 16) . FcγRIIa has been described as a potent immune-activating receptor and it contains an ITAM motif, capable of mediating phagocytosis, ADCC, and initiation of infl ammatory cytokine release (17) .
Here, we show that human pDCs can indeed take up exogenous antigen through CD32/FcγRII and stimulate antigenspecifi c CD4 + T cells.
RESULTS AND D I S C U S S I O N
Plasmacytoid DCs are able to take up exogenous antigen pDCs can induce alloresponses (18) , drive Th1 polarization (19) , and are able to prime specifi c CD4 + and CD8 + T cells when loaded with tumor peptides or upon viral infection (12) . The previously reported poor ability of this subpopulation of human DCs to generate primary specifi c CD4 + T cell responses has been attributed to their apparent lack of an efficient machinery to internalize soluble proteins (2) . Here, we investigated the capacity of highly purifi ed pDCs (purity 96.5 ± 1.8%, Fig. 1 A) to internalize KLH conjugated to the fl uorescent dye Alexa Fluor 488 ( Figs. 1 and 2) . No internalization of KLH was observed when pDCs were isolated from the blood of normal donors or of melanoma patients not vaccinated with KLH-loaded monocyte-derived DCs (Fig. 1 B) . Surprisingly, we observed that KLH was effi ciently taken up by freshly isolated pDCs from patients (n = 3; mean 45 ± 13% positive cells; Fig. 1 B) who were vaccinated with KLHloaded monocyte-derived DCs. These patients all had high levels of specifi c antibodies to KLH of the IgG isotype ( Fig.  1 C) . In contrast, pDCs from patients (n = 2) vaccinated with KLH-loaded DCs, but who did not form IgG antibodies directed against KLH, did not take up this protein (Fig. 2 A) . This further supports the notion that uptake is dependent on the presence of KLH antibodies. The scatter plot (side and forward scatter) of pDCs isolated by positive sorting using anti-BDCA-4-conjugated magnetic microbeads is shown. Purity was checked by double staining using BDCA-2 (CD302) and IL-3 receptor (CD123). (B) pDCs were isolated from blood of normal donors, nonvaccinated melanoma patients, and melanoma patients vaccinated with KLH-loaded monocyte-derived DCs. Only pDCs isolated from blood of vaccinated patients who developed a humoral response against KLH were able to take up KLH (right), whereas pDCs isolated from healthy donors or before vaccination (left and middle) were not able to take up exogenous protein. 
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Antigen uptake is postvaccination serum dependent
The fi ndings presented in Fig. 2 provide further evidence that only in the presence of serum-containing IgG directed against KLH (Fig. 2 B , black line) pDCs were able to take up the exogenous KLH in a serum concentration dependent way. In the presence of serum obtained from patients prevaccination (Fig. 2 B, dotted line) or serum from healthy donors (Fig. 2 A) , KLH was not internalized. Internalization was confi rmed by confocal microscopy imaging (Fig. 2 C A predominant role for antibody-mediated interna lization of proteins is described for the IgG receptor CD32 (20) . Here, we confi rm previous data on the expression of CD32 by pDCs ( Fig. 3 A and Fig. S2 , available at http://www. jem.org/cgi/content/full/jem.20052364/DC1) (15, 16) . The uptake of KLH was inhibited when antibodies specifi c for this receptor were added (Fig. 3 B) . These data demonstrate that the uptake of KLH is mediated by antigen-specifi c IgG anti bodies binding to CD32. The fi nding that pDCs freshly isolated from blood of vaccinated patients were able to internalize KLH without the addition of antibody-containing serum suggests the presence of antigen-specifi c antibodies on the surface of circulating pDCs in vivo.
Fc receptors have previously been implicated in the uptake of foreign particles and macromolecules by myeloid and monocyte-derived DCs, as such reducing the concentration of antigen required for T cell activation. After proper routing and processing, the uptake of antigens via Fc receptors by monocyte-derived DC not only results in CD4-mediated T cell responses but ultimately in cross-presentation of exogenous antigen to CD8 + T cells (20) . (22) . Here, we confi rm their data by really showing complexes of KLHAlexa inside the pDCs by confocal microscopy ( Fig. 2 C and Video 1). Furthermore, we extend their observations by showing that human pDCs not only take up immune complexes via FcγRII but also effi ciently present internalized antigen to CD4 + T cells. We incubated PBLs from patients with a cellular response to KLH with autologous pDCs pulsed with KLH. pDCs from patients who lacked a humoral response against KLH were not able to induce KLH-specifi c proliferation (Fig. 4 A) , corresponding to the lack of KLH uptake. This could not be attributed to the absence of specifi c T cells because monocyte-derived DCs loaded with KLH effi ciently induced a proliferative response (Fig. S3 , available at http://www.jem.org/cgi/content/full/jem.20052364/DC1). In contrast, pDCs from patients with a positive humoral response against KLH were able to induce a specifi c proliferative response of PBLs (Fig. 4 B) and purifi ed CD4 + T cells (Fig.  4 C) . Furthermore, we investigated whether pretreatment of pDCs with anti-CD32 mAb could also inhibit the KLHspecifi c proliferation. In Fig. 5 A, it is shown that anti-CD32 pretreatment with mAb signifi cantly inhibits the specifi c KLH proliferation. In accordance with the incomplete inhibition by anti-CD32 mAb of the KLH uptake (Fig. 3 B) , the proliferation was not completely abrogated (Fig. 5 A) . These fi ndings demonstrate that serum containing KLH-specifi c Ab appeared essential for the uptake of KLH. To further substantiate this fi nding to KLH presentation by pDCs to T cells, we incubated pDCs with pre-and postvaccination serum. As depicted in Fig. 5 B, only pDCs incubated with postvaccination serum mediated PBLs and CD4 T cell proliferation and division in response to KLH (Fig. 5 B and Fig. S4 , available at http://www.jem.org/cgi/content/full/jem.20052364/DC1). These fi ndings indicate the necessity of antigen-specifi c antibodies for uptake and presentation of exogenous antigens.
KLH is processed and presented to antigen-specifi c T cells
Collectively, our observations demonstrate that pDCs can take up, process, and present exogenous antigen, resulting in a memory T cell response. We propose that pDCs not only nonspecifi cally support innate immunity by the secretion of type I interferons but also support a secondary type of immune response. Based on the results shown in this study, pDCs may play a role in the presentation of exogenous antigens, inducing a memory type of response.
In vivo the immunological outcome of pDC-mediated T cell stimulation will much depend on the activation state serum. Freshly isolated pDCs were only able to induce a proliferative T cell response against KLH when anti-KLH antibodies were present in vivo (see Fig. 1 B for internalization) . No increased proliferation was observed when irrelevant control protein was added (not depicted). Signifi cant differences from control according to Student's t test: *, P < 0.05; **, P < 0.001.
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of the pDC (6) . Resting pDCs are thought to play an essential role in maintaining tolerance. In cancer patients, pDCs are found in the tumor tissue, but seem inactive despite the fact that circulating antibodies against tumor-associated proteins may be present (7, 23) . Although resting pDCs express FcγRII and can therefore internalize immune complexes, they express only low amounts of MHC class II and do not secrete signifi cant amounts of type I interferons. These last characteristics might favor tolerance rather than induction of immunostimulatory T cell responses (6) . Therefore, the balance between immunity and tolerance (24) will critically depend on the activation state of the pDC.
Recent studies have shown that pDCs may also accumulate in peripheral tissues during certain noninfectious infl ammatory diseases, including autoimmune disorders such as psoriasis. It has been indicated that pDCs initiate psoriasis through type I interferon production (25) . Also, in systemic lupus erythematosus (SLE), another autoimmune disorder, circulating pDCs are decreased, but large numbers of activated pDCs infi ltrate the skin lesions actively producing type I interferon in these patients (26, 27) . Immune complexes, consisting of pathogenic autoantibodies and DNA derived from apoptotic cells, stimulate pDCs to produce cytokines and chemokines via a cooperative interaction between Toll-like receptor 9 and FcγRII (22, 28) . Here, we hypothesize that the endogenous DNAcontaining autoantibody complexes found in serum of patients with SLE not only lead to type I IFN production but also could play a role in the adaptive immune response by stimulating autoantigen-specifi c T cells in SLE patients.
Finally, our fi nding that FcγRII may serve as an important antigen uptake receptor for pDCs may result in the development of strategies to target antigens to pDCs in therapeutic settings. In autoimmune diseases, the role of pDCs is coming to the fore; for cancer or infectious diseases, antigen targeting to pDCs may prove a promising approach to modulate tolerance or immunostimulation.
MATERIALS AND METHODS
Cells. pDCs were purifi ed from PBLs by positive isolation using anti-BDCA-4-conjugated magnetic microbeads (Miltenyi Biotec) and adjusted to 10 6 cells/ml in X-VIVO-15 (Cambrex) supplemented with 10 ng/ml IL-3.
Flow cytometry. CD32 staining and blocking were performed using anti-CD32 (clone AT-10; Serotec), mouse isotype control IgG1, and as secondary mAb PE-conjugated goat anti-mouse. Mean fl uorescence intensity and percentage of positive cells were determined by fl ow cytometry.
Clinical vaccination protocol.
PBLs and monocyte-derived DCs were isolated from melanoma patients participating in ongoing DC vaccination trials (29) . The study was approved by the local regulatory committee and written informed consent was obtained from all patients. Antigen-pulsed monocyte-derived DCs (gp100 peptides, tyrosinase peptide and KLH) were administered intravenously and intradermally.
Humoral responses to KLH. Humoral responses to KLH were determined by ELISA (30) .
KLH internalization assays. Endotoxin-free protein KLH was purchased from Calbiochem and control protein carcinogenic embryonic antigen was obtained from Abcam. Protein binding and internalization by pDCs was assessed by direct labeling of protein with the Alexa Fluor 488 labeling kit (GE Healthcare). pDCs were incubated with 10 μg/ml Alexa-labeled Figure 5 . Role of anti-CD32 antibodies and anti-KLH antibodycontaining sera in pDC-induced T cell proliferation. (A) pDCs isolated from patients before vaccination were incubated with anti-KLH antibodycontaining serum in the presence of KLH. Anti-CD32 antibodies were added to investigate the role of this receptor. After overnight incubation, pDCs were washed and cocultured with PBLs (black bars) or CD4 + T cells (white bars) in X-VIVO 15 supplemented with 2% pooled human serum. Proliferation was measured after 48 h. For normalization, proliferation is depicted as relative proliferation. Maximum proliferation (T cell proliferation induced by KLH-loaded pDCs in the presence of isotype control antibody) of each experiment was set at 100 and relative proliferation (T cell proliferation induced by KLH-loaded pDCs in the presence of anti-CD32 antibody) was calculated per experiment. In the presence of anti-CD32 antibodies, a signifi cant inhibition of the proliferation was observed (Student's t test). (B) pDCs isolated from patients before vaccination were incubated with either postvaccination serum (containing anti-KLH antibodies) or prevaccination serum (no antibodies against KLH) in the presence of KLH. After overnight incubation, pDCs were washed and cocultured with PBLs (black bars) or CD4 + T cells (white bars) in X-VIVO 15 supplemented with 2% pooled human serum. Proliferation was measured after 48 h. For normalization, proliferation is depicted as relative proliferation. Maximum proliferation (T cell proliferation induced by pDCs in the presence of postvaccination serum and KLH) of each experiment was set at 100 and relative proliferation (T cell proliferation induced by pDCs in the presence prevaccination serum and KLH) was calculated per experiment. Proliferation was predominantly observed in the presence of postvaccination serum (containing anti-KLH antibodies) and KLH. p-values indicate signifi cant differences from maximum to Student's t test.
protein overnight at 37°C. Subsequently, cells were washed and analyzed by fl ow cytometry.
Internalization of Alexa-labeled KLH was confi rmed by confocal laser scanning microscopy. pDCs were incubated overnight with 10 μg/ml Alexa-labeled KLH in the presence of post-or prevaccination serum. Cells were fi xed on poly-L-lysine coated glass slides, followed by staining with MHC class II mAb (clone Q5/13) or IgG2a isotype control as a secondary mAb goat anti-mouse Alexa 647 was used. Cells were imaged with a BioRad MRC 1024 confocal system operating on a Nikon Optiphot microscope and a Nikon 60x planApo 1.4 oil immersion lens. Pictures were analyzed with Bio-Rad Lasersharp 2000 and Adobe Photoshop 7.0 (Adobe Systems) software.
Cellular responses to KLH. pDCs were washed and cocultured with KLH-responsive PBLs or purifi ed CD4 + T cells at 37°C. pDCs were incubated overnight with 5% pre-or postvaccination serum. Pretreatment with anti-CD32 antibody was performed for 20 min at 4°C followed by the overnight incubation with the appropriate serum. After 2-4 d of coculture, a tritiated thymidine incorporation assay was performed. Tritiated thymidine (1 μCi/well; MP Biomedicals) was added to the cell cultures and incorporation was measured after 16 h. (10 5 ) were cultured with the indicated stimulus for 2 d, and subsequently, CFSE fl uorescence intensity was measured by fl ow cytometry.
CFSE-labeled (1 μM) T cells. CFSE-labeled cells
Statistics. All cultures were performed in triplicate and results are shown as the mean ± SD. Signifi cant diff erence from control according to Student's t test.
Online supplemental material. Fig. S1 shows the fl ow cytometric data concerning the uptake of KLH-Alexa of the same cells as used in Fig. 2 C. Fig. S2 shows CD32 expression by pDCs measured with diff erent clones of antibodies recognizing CD32. Fig. S3 shows that the patients analyzed in Fig. 4 do have specifi c T cells. Fig. S4 shows the comparison of T cell division and T cell proliferation both induced by KLH-loaded pDCs. Video 1 shows a z-scan analysis of pDCs stained with MHC class II antibodies (red) and internalized KLH-Alexa (green). Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20052364/DC1.
